Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 10 2024
0mins
Source: Globenewswire
Company Announcement: Boundless Bio will participate in the 2024 Cantor Global Healthcare Conference with a fireside chat scheduled for September 18, 2024, featuring CEO Zachary Hornby and CFO Jami Rubin.
About Boundless Bio: The company focuses on developing therapies targeting extrachromosomal DNA (ecDNA) to treat oncogene amplified cancers, with two clinical trials underway for their ecDNA-directed therapies, BBI-355 and BBI-825.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
